Intellectual Property
Dec. 1, 2020
Choosing how to protect COVID-19-related inventions
The COVID-19 pandemic has prompted an intense and wide-ranging stampede by pharmaceutical companies, research institutions, physicians and health care practitioners to find preventative, curative and symptom treatments for the flu-like illness.





Dariush Adli
President
ADLI Law Group
444 S Flower St
Los Angeles , CA 90071
Email: adli@adlilaw.com
Univ of Michigan Law Sch; Ann Arbor MI
The COVID-19 pandemic has prompted an intense and wide-ranging stampede by pharmaceutical companies, research institutions, physicians and health care practitioners to find preventative, curative and symptom treatments for the flu-like illness. Existing and proposed COVID-19 treatments range from vaccines to medicines, used alone or in combination with other medications, administrative and intervention measures, and dosage regimen.
I...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In